I get the feeling that RXP is tracking to an annual revenue base of $20m. In the half year they specified that they are achieving 18% NPAT margin. If you annualise quarterly receipts this may happen. If they deliver on this, and if you add in the acquisition earnings then RXP is shaping up to be a very cheap play. Just need confirmation, and a much higher price to improve liquidity ;)
